Company news
Bolt Biotherapeutics, Inc. news in 2025
Bolt Biotherapeutics, Inc.'s news releases, calls and decks from 2025, newest first.
Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
November 12, 2025
Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027
October 1, 2025
Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
August 14, 2025
Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
May 12, 2025
Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates
May 8, 2025
Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody(TM) ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025
April 30, 2025
Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025
April 30, 2025
Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025
April 25, 2025
Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025
March 25, 2025
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
March 24, 2025
Bolt Biotherapeutics to Participate in Upcoming March Conferences
February 25, 2025
Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.
February 10, 2025